Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model.
Adenocarcinoma
/ therapy
Animals
CD8-Positive T-Lymphocytes
/ immunology
Cancer Vaccines
/ immunology
Carcinoma, Pancreatic Ductal
/ therapy
Cell Line, Tumor
Dendritic Cells
/ immunology
Disease Models, Animal
Female
Humans
Lymph Nodes
/ cytology
Mice
Mice, Inbred C57BL
Neoplasm Recurrence, Local
/ prevention & control
Pancreatic Neoplasms
/ therapy
Vaccination
Pancreatic Neoplasms
dendritic cell vaccines
magnetic resonance imaging
pancreatic cancer
prevention
Journal
Cytotherapy
ISSN: 1477-2566
Titre abrégé: Cytotherapy
Pays: England
ID NLM: 100895309
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
13
03
2019
revised:
29
11
2019
accepted:
01
12
2019
entrez:
2
2
2020
pubmed:
2
2
2020
medline:
4
8
2020
Statut:
ppublish
Résumé
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths with high recurrence after surgery due to a paucity of effective post-surgical adjuvant treatments. DC vaccines can activate multiple anti-tumor immune responses but have not been explored for post-surgery PDAC recurrence. Intraperitoneal (IP) delivery may allow increased DC vaccine dosage and migration to lymph nodes. Here, we investigated the role of prophylactic DC vaccination controlling PDAC tumor growth with IP delivery as an administration route for DC vaccination. DC vaccines were generated using ex vivo differentiation and maturation of bone marrow-derived precursors. Twenty mice were divided into four groups (n = 5) and treated with DC vaccines, unpulsed mature DCs, Panc02 lysates or no treatment. After tumor induction, mice underwent three magnetic resonance imaging scans to track tumor growth. Apparent diffusion coefficient (ADC), a quantitative magnetic resonance imaging measurement of tumor microstructure, was calculated. Survival was tracked. Tumor tissue was collected after death and stained with hematoxylin and eosin, Masson's trichrome, terminal deoxynucleotidyl transferase dUTP nick end labeling and anti-CD8 stains for histology. DC-vaccinated mice demonstrated stronger anti-tumor cytotoxicity compared with control groups on lactate dehydrogenase assay. DC vaccine mice also demonstrated decreased tumor volume, prolonged survival and increased ΔADC compared with control groups. On histology, the DC vaccine group had increased apoptosis, increased CD8+ T cells and decreased collagen. ΔADC negatively correlated with % collagen in tumor tissues. Prophylactic DC vaccination may inhibit PDAC tumor growth during recurrence and prolong survival. ΔADC may be a potential imaging biomarker that correlates with tumor histological features.
Identifiants
pubmed: 32005355
pii: S1465-3249(19)30915-6
doi: 10.1016/j.jcyt.2019.12.001
pii:
doi:
Substances chimiques
Cancer Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6-15Subventions
Organisme : NCI NIH HHS
ID : R01 CA209886
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA196967
Pays : United States
Informations de copyright
Copyright © 2019 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved.